A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treatedwith PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029

Project: Research project

Project Details

Description

A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treated with PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029
StatusActive
Effective start/end date12/1/1711/30/22

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.